IRIS
MANZO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.889
AS - Asia 2.142
EU - Europa 1.645
SA - Sud America 332
Continente sconosciuto - Info sul continente non disponibili 262
AF - Africa 78
OC - Oceania 1
Totale 7.349
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.807
CN - Cina 952
SG - Singapore 485
IE - Irlanda 349
HK - Hong Kong 254
BR - Brasile 245
VN - Vietnam 229
RU - Federazione Russa 206
DE - Germania 196
IT - Italia 187
FI - Finlandia 164
UA - Ucraina 155
SE - Svezia 105
FR - Francia 100
GB - Regno Unito 80
BD - Bangladesh 49
CA - Canada 49
ZA - Sudafrica 45
IN - India 36
AR - Argentina 24
EC - Ecuador 19
BE - Belgio 18
ES - Italia 17
JP - Giappone 17
MX - Messico 17
PK - Pakistan 16
CO - Colombia 14
IQ - Iraq 14
CZ - Repubblica Ceca 13
NL - Olanda 13
TR - Turchia 13
ID - Indonesia 12
PL - Polonia 12
SA - Arabia Saudita 9
VE - Venezuela 9
AT - Austria 8
CL - Cile 8
MA - Marocco 8
MY - Malesia 7
PH - Filippine 7
PE - Perù 6
TN - Tunisia 6
UZ - Uzbekistan 5
KZ - Kazakistan 4
LT - Lituania 4
CR - Costa Rica 3
EG - Egitto 3
IL - Israele 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
LB - Libano 3
NP - Nepal 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BO - Bolivia 2
CU - Cuba 2
ET - Etiopia 2
KW - Kuwait 2
PS - Palestinian Territory 2
QA - Qatar 2
RO - Romania 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AO - Angola 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GN - Guinea 1
GR - Grecia 1
HN - Honduras 1
HT - Haiti 1
IR - Iran 1
KG - Kirghizistan 1
KR - Corea 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MQ - Martinica 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
Totale 7.080
Salva come PNG Salva come JPEG
Città #
Dublin 347
San Jose 327
Chandler 323
Singapore 252
Ashburn 245
Hong Kong 244
Jacksonville 219
Dallas 202
Beijing 176
Nanjing 169
Council Bluffs 110
Boardman 103
Ho Chi Minh City 84
New York 78
Nanchang 77
Lauterbourg 70
Princeton 69
Lawrence 66
Wilmington 65
Los Angeles 64
Changsha 63
Munich 60
Ann Arbor 57
Helsinki 57
Hebei 56
Shenyang 56
Hanoi 53
Jiaxing 41
Medford 40
Johannesburg 39
Pavia 39
Shanghai 39
Buffalo 33
Milan 33
Santa Clara 32
Moscow 30
Redondo Beach 30
Tianjin 26
Piscataway 22
São Paulo 22
Hangzhou 21
Montreal 21
Da Nang 20
Turku 20
Brussels 18
Toronto 17
Tokyo 14
Columbus 13
Seattle 13
Brooklyn 12
Frankfurt am Main 12
The Dalles 12
Woodbridge 12
Denver 11
Houston 11
Phoenix 11
Rio de Janeiro 11
Nuremberg 10
Warsaw 10
Washington 10
London 9
Zhengzhou 9
Baghdad 8
Brno 8
Mexico City 8
Norwalk 8
Orem 8
Rome 8
Stockholm 8
Amsterdam 7
Atlanta 7
Boston 7
Chennai 7
Fairfield 7
Medellín 7
Quito 7
San Francisco 7
Guayaquil 6
Haiphong 6
Manchester 6
Turin 6
Brasília 5
Guangzhou 5
Guarulhos 5
Kunming 5
Poplar 5
Porto Alegre 5
Ribeirão Preto 5
Santiago 5
Secaucus 5
Tappahannock 5
Verona 5
Auburn Hills 4
Belo Horizonte 4
Caxias do Sul 4
Chongqing 4
Dearborn 4
Delhi 4
Dhaka 4
Elk Grove Village 4
Totale 4.638
Salva come PNG Salva come JPEG
Nome #
Assessment of synovitis to predict bone erosions in rheumatoid arthritis 153
B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers 147
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis 142
Methotrexate and glucocorticoids, but not anticytokine therapy, impair the immunogenicity of a single dose of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic inflammatory arthritis 140
Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome 126
Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium 122
Chemochine linfoidi nella sinovite reumatoide 121
Synovial tissue research: a state-of-the-art review 121
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis 120
Reactogenicity, safety and disease flares following BNT162b2 mRNA COVID-19 vaccine in patients with chronic immune-inflammatory arthritis treated with biological and targeted synthetic disease-modifying anti-rheumatic drugs 119
T o B nell’Artrite Reumatoide 118
Clinical, Imaging, and Pathological Suppression of Synovitis in Rheumatoid Arthritis: Is the Disease Curable? 118
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study 117
B cell autoimmunity and bone damage in rheumatoid arthritis 117
Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis 113
Chemokines in arthritis: key molecules in pathogenesis and potential therapeutic targets 112
A Multicenter Retrospective Analysis Evaluating Performance of Synovial Biopsy Techniques in Patients With Inflammatory Arthritis: Arthroscopic Versus Ultrasound-Guided Versus Blind Needle Biopsy 112
Current concepts and new developments in the treatment of psoriatic arthritis 112
Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs' 110
Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography 109
Challenges in the diagnosis of early rheumatoid arthritis in times of COVID-19 109
B cell synovitis and clinical phenotypes in rheumatoid arthritis: relationship to disease stages and drug exposure 107
Counter-regulation of regulatory T cells by autoreactive CD8+ T cells in rheumatoid arthritis. 106
Multilevel examination of minor salivary gland biopsy for Sjogren’s syndrome significantly improves diagnostic performance of AECG classification criteria 105
Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis 105
Role of chemokines in the pathogenesis of chronic synovitis during rheumatoid arthritis 104
Role of chemokines and chemokine receptors in regulating specific leukocyte trafficking in the immune/inflammatory response 103
Inflammatory correlates of the Patient Global Assessment of Disease Activity vary in relation to disease duration and autoantibody status in patients with rheumatoid arthritis 96
The circulating interferon-inducible protein IFI16 correlates with clinical and serological features in rheumatoid arthritis 96
No evidence of short-term impact of repeated BNT162b2 vaccination on rheumatoid arthritis homeostasis in drug-free remission 95
Role of cell migration in the pathogenesis of rheumatoid arthritis: in vivo studies in SCID mice transplanted with human synovial membrane 95
Established rheumatoid arthritis. The pathogenic aspects. 95
Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target 94
Insights Into the Concept of Rheumatoid Arthritis Flare 94
A “Window of Therapeutic Opportunity” for Anti-Cytokine Therapy in Patients With Coronavirus Disease 2019 93
Meccanismi di danno articolare in corso di artrite reumatoide 92
Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis 92
Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment 90
Nuovi aspetti patogenetici dell’artrite reumatoide 90
The draining lymph node in rheumatoid arthritis: current concepts and research perspectives 90
Limiting factors to Boolean remission differ between autoantibody-positive and -negative patients in early rheumatoid arthritis 88
Synovial tissue heterogeneity and peripheral blood biomarkers 87
IL-6 amplifies TLR mediated cytokine and chemokine production: implications for the pathogenesis of rheumatic inflammatory diseases 86
High serum levels of CXCL13 predict lower response to csDMARDs in both ACPA-positive and ACPA-negative early rheumatoid arthritis 85
Synovial and serum B-cell signature of autoantibody-negative rheumatoid arthritis versus autoantibody-positive rheumatoid arthritis and psoriatic arthritis 85
Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084,in a mouse model of motor neuron disease not linked to SOD1 mutation 85
Timely escalation to second-line therapies after failure of methotrexate in patients with early rheumatoid arthritis does not reduce the risk of becoming difficult-to-treat 82
Prediction of long-term drug-free outcomes in ACPA-positive and ACPA-negative rheumatoid arthritis by combined clinical and ultrasound assessment of residual disease: a 5-year prospective study 82
Use of ultrasound-guided small joint biopsy to evaluate the histopathologic response to rheumatoid arthritis therapy: recommendations for application to clinical trials 82
Secondary and ectopic lymphoid tissue responses in rheumatoid arthritis: from inflammation to autoimmunity and tissue damage/remodeling 81
Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs 81
La membrana sinoviale 80
Immunohistological assessment of the synovial tissue in small joints in rheumatoid arthritis: validation of a minimally invasive ultrasound-guided synovial biopsy procedure 79
Targeting of viral interleukin-10 with an antibody fragment specific to damaged arthritic cartilage improves its therapeutic potency 78
Lymphoid tissue reactions in rheumatoid arthritis 77
Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors. 77
Clinical Applications of Synovial Biopsy. 75
Tender joints in early autoantibody-negative rheumatoid arthritis: Should they be included in the scoring of joint involvement of the 2010 ACR/EULAR classification criteria? 74
High expression levels of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease 72
Progressive increase in time to referral and persistently severe clinical presentation over the years in autoantibody-negative patients with rheumatoid arthritis in the setting of an early arthritis clinic 72
Seronegative rheumatoid arthritis: one year in review 2023 70
Human single-chain variable fragment that specifically targets arthritic cartilage 69
Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases 69
La linfoneogenesi 69
Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice 68
Evaluation of Minimally Invasive, Ultrasound-guided Synovial Biopsy Techniques by the OMERACT Filter-Determining Validation Requirements 68
The access route through the anatomical snuffbox in ultrasound-guided synovial biopsy of the wrist allows for a safe and effective collection of tissue samples in inflammatory arthritis 66
The Clinical Value of Autoantibodies in Rheumatoid Arthritis. 66
The synovial membrane as a prognostic tool in rheumatoid arthritis 62
Stromal cell-derived factor 1 (CXCL12) induces human cell migration into human lymph nodes transplanted into SCID mice 61
Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course 60
Correction to: Standardisation of synovial biopsy analyses in rheumatic diseases: A consensus of the eular synovitis and omeract synovial tissue biopsy groups (Arthritis Research and Therapy (2018) 20 (265) DOI: 10.1186/s13075-018-1762-1) 59
Mature antigen-experienced T helper cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of the rheumatoid joint 59
Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups. 55
Inflammatory lesions in the bone marrow of rheumatoid arthritis patients: a morphological perspective 55
Power Doppler ultrasonographic assessment of the joint-draining lymph node complex in rheumatoid arthritis: a prospective, proof-of-concept study on treatment with tumor necrosis factor inhibitors 54
The Genetic, Environmental, and Immunopathological Complexity of Autoantibody-Negative Rheumatoid Arthritis 53
Targeting the IL-6-Yap-Snail signalling axis in synovial fibroblasts ameliorates inflammatory arthritis 53
Histopathology of the synovial tissue: Perspectives for biomarker development in chronic inflammatory arthritides. 53
Redox-Mediated Mechanisms Fuel Monocyte Responses to CXCL12/HMGB1 in Active Rheumatoid Arthritis. 50
ProNGF-p75NTR axis plays a proinflammatory role in inflamed joints: a novel pathogenic mechanism in chronic arthritis 47
EULAR points to consider for minimal reporting requirements in synovial tissue research in rheumatology 39
ERRATUM to: Synovial tissue research: a state-of-the-art review (Nature Reviews Rheumatology 13, 463–475 (2017)) 36
Totale 7.349
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.129
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.129
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022275 0 2 13 12 3 19 4 28 10 9 38 137
2022/20231.018 107 75 6 72 94 93 2 57 402 10 34 66
2023/2024478 39 110 17 33 39 140 13 28 4 8 28 19
2024/20251.133 20 86 16 15 10 54 77 61 289 57 155 293
2025/20262.704 218 217 333 272 284 106 511 159 200 193 124 87
2026/2027183 37 146 0 0 0 0 0 0 0 0 0 0
Totale 7.349